WO2002094877A3 - Nouveaux cofacteurs de recepteur nucleaire et modulateurs correspondants - Google Patents
Nouveaux cofacteurs de recepteur nucleaire et modulateurs correspondants Download PDFInfo
- Publication number
- WO2002094877A3 WO2002094877A3 PCT/IB2002/002939 IB0202939W WO02094877A3 WO 2002094877 A3 WO2002094877 A3 WO 2002094877A3 IB 0202939 W IB0202939 W IB 0202939W WO 02094877 A3 WO02094877 A3 WO 02094877A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- nuclear receptor
- cofactors
- ppar
- gamma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- High Energy & Nuclear Physics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002319847A AU2002319847A1 (en) | 2001-05-23 | 2002-05-23 | New nuclear receptor cofactors and related modulators |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29252601P | 2001-05-23 | 2001-05-23 | |
US60/292,526 | 2001-05-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002094877A2 WO2002094877A2 (fr) | 2002-11-28 |
WO2002094877A3 true WO2002094877A3 (fr) | 2004-06-10 |
Family
ID=23125029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2002/002939 WO2002094877A2 (fr) | 2001-05-23 | 2002-05-23 | Nouveaux cofacteurs de recepteur nucleaire et modulateurs correspondants |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002319847A1 (fr) |
WO (1) | WO2002094877A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040037828A1 (en) | 2002-07-09 | 2004-02-26 | Bar-Ilan University | Methods and pharmaceutical compositions for healing wounds |
CA2535029C (fr) | 2003-08-07 | 2013-07-16 | Healor Ltd. | Compositions pharmaceutiques et methodes permettant d'accelerer la cicatrisation de plaies |
EP2452691A3 (fr) | 2005-08-29 | 2012-09-05 | HealOr Ltd. | Procédés et compositions pour la prévention du diabète et du vieillissement de la peau |
WO2009043953A1 (fr) * | 2007-10-05 | 2009-04-09 | Proyecto De Biomedicina Cima, S.L. | Utilisation d'inhibiteurs de ppar alpha tronqué dans le traitement de l'insuffisance cardiaque chez des sujets souffrant de cardiopathie hypertensive |
CA2789972A1 (fr) | 2010-01-11 | 2011-07-14 | Healor Ltd. | Procede pour traiter une maladie et un trouble inflammatoires |
-
2002
- 2002-05-23 WO PCT/IB2002/002939 patent/WO2002094877A2/fr not_active Application Discontinuation
- 2002-05-23 AU AU2002319847A patent/AU2002319847A1/en not_active Abandoned
Non-Patent Citations (7)
Title |
---|
COLLINGWOOD T N ET AL: "NUCLEAR RECEPTORS: COACTIVATORS, COREPRESSORS AND CHROMATIN REMODELING IN THE CONTROL OF TRANSCRIPTION", JOURNAL OF MOLECULAR ENDOCRINOLOGY, XX, XX, vol. 23, 1999, pages 255 - 275, XP001050651, ISSN: 0952-5041 * |
DATABASE GENBANK [online] 22 May 2001 (2001-05-22), NIH-MGC: "NIH_MGC_17 Homo sapiens cDNA clone IMAGE:4900666 5', mRNA sequence", XP002245760, retrieved from NCBI Database accession no. BG825152 * |
DATABASE GENBANK [online] 8 February 2001 (2001-02-08), "Mus musculus adult male cerebellum cDNA, clone:1500001J14", XP002245761, retrieved from NCBI Database accession no. AK005094 * |
HANKE J ET AL: "Alternative splicing of human genes: more the rule than the exception?", TRENDS IN GENETICS, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, vol. 15, no. 10, 1 October 1999 (1999-10-01), pages 389 - 390, XP004179550, ISSN: 0168-9525 * |
RING H Z ET AL: "Five SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin (SMARC) genes are dispersed in the human genome", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 51, no. 1, 1 July 1998 (1998-07-01), pages 140 - 143, XP002223620, ISSN: 0888-7543 * |
ZHU Y ET AL: "ISOLATION AND CHARACTERIZATION OF PBP, A PROTEIN THAT INTERACTS WITH PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 41, 10 October 1997 (1997-10-10), pages 25500 - 25506, XP002915089, ISSN: 0021-9258 * |
ZHU Y ET AL: "Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. UNITED STATES 5 MAY 2000, vol. 275, no. 18, 5 May 2000 (2000-05-05), pages 13510 - 13516, XP002245759, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002094877A2 (fr) | 2002-11-28 |
AU2002319847A1 (en) | 2002-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002345497A1 (en) | Cips as modifiers of the p53 pathway and method of use | |
WO2008115518A3 (fr) | Biomarqueurs de l'activité sirtuine et procédés d'utilisation de ceux-ci | |
ATE413386T1 (de) | Ppar-gamma modulatoren | |
WO2004015130A3 (fr) | Modulateurs de rabggt et procedes d'utilisation de ceux-ci | |
NO20013156L (no) | Fremgangsmate ved anvendelse av en cyklooksygenase-2- inhibitor, samt en matrise-metalloproteinase-inhibitor som enkombinasjonsbehandling ved behandling av neoplasier | |
WO2003002717A3 (fr) | Activite biologique de ak155 | |
WO2005027839A3 (fr) | Procedes et reactifs pour le traitement des troubles immuno-inflammatoires | |
MX2008009579A (es) | Metodo para el tratamiento de dolor neuropatico. | |
WO2003014299A3 (fr) | Sphingosine kinase (sphk) en tant que modificateurs de la voie de passage p53 et methodes d'utilisation | |
WO2004032851A3 (fr) | Criblage et procedes therapeutiques lies a la neurogenese | |
BR0313792A (pt) | Utilização de proteìna de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento | |
HK1037722A1 (en) | Modulating multiple lineage kinase proteins. | |
WO2002094877A3 (fr) | Nouveaux cofacteurs de recepteur nucleaire et modulateurs correspondants | |
EP1254260A4 (fr) | Methodes pour diagnostiquer et traiter une maladie du coeur | |
WO2005061002A3 (fr) | Composition et procedes pour la modulation de l'activite du systeme nerveux central | |
WO2002078606A3 (fr) | Thrombospondine-2 et ses utilisations | |
EP1255110A3 (fr) | Méthodes et produits pour l'identification de modulateurs de l'activité des récepteurs P2X7, et leur utilisation pour le traitement des affections squelettiques | |
ATE288498T1 (de) | Methoden zur inhibierung von helicobacter pylori | |
WO2002062205A3 (fr) | Methodes de diagnostic et de traitement des cardiopathies | |
WO2002014536A3 (fr) | Procedes permettant de moduler des proteines kinase a lignee multiple et de cribler des composes les modulant | |
EP1532446A4 (fr) | Ligands des recepteurs couples aux proteine g et methodes | |
WO2003028536A3 (fr) | Methodes permettant de diagnostiquer et de traiter les maladies cardiaques | |
WO2002058323A3 (fr) | Dosage | |
EP1438432A4 (fr) | Lrrcaps en tant que modificateurs de la voie de passage p53 et leurs procedes d'utilisation | |
WO2004065542A3 (fr) | Mat2a utilises comme modificateurs de la voie p53 et procedes d'utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |